AU6006000A - Chemical compounds-iii - Google Patents

Chemical compounds-iii

Info

Publication number
AU6006000A
AU6006000A AU60060/00A AU6006000A AU6006000A AU 6006000 A AU6006000 A AU 6006000A AU 60060/00 A AU60060/00 A AU 60060/00A AU 6006000 A AU6006000 A AU 6006000A AU 6006000 A AU6006000 A AU 6006000A
Authority
AU
Australia
Prior art keywords
iii
chemical compounds
compounds
chemical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU60060/00A
Other languages
English (en)
Inventor
Mike Frederick Snape
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ligand UK Research Ltd
Original Assignee
Vernalis Research Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vernalis Research Ltd filed Critical Vernalis Research Ltd
Publication of AU6006000A publication Critical patent/AU6006000A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Toxicology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU60060/00A 1999-07-23 2000-07-21 Chemical compounds-iii Abandoned AU6006000A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9917384.1A GB9917384D0 (en) 1999-07-23 1999-07-23 Chemical compounds-III
GB9917384 1999-07-23
PCT/GB2000/002817 WO2001007022A2 (fr) 1999-07-23 2000-07-21 Composes chimiques iii

Publications (1)

Publication Number Publication Date
AU6006000A true AU6006000A (en) 2001-02-13

Family

ID=10857862

Family Applications (1)

Application Number Title Priority Date Filing Date
AU60060/00A Abandoned AU6006000A (en) 1999-07-23 2000-07-21 Chemical compounds-iii

Country Status (5)

Country Link
EP (1) EP1196165A2 (fr)
JP (1) JP2003505413A (fr)
AU (1) AU6006000A (fr)
GB (1) GB9917384D0 (fr)
WO (1) WO2001007022A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8586572B2 (en) * 2008-11-24 2013-11-19 Integrative Research Laboratories Sweden Ab 3-phenyl-azetidine derivatives useful as modulators of cortical catecholaminergic neurotransmission
GB201415598D0 (en) 2014-09-03 2014-10-15 Univ Birmingham Elavated Itercranial Pressure Treatment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB872447A (en) * 1958-12-23 1961-07-12 Lepetit Spa 1-carbamyl-3-substituted azetidines
ATE220665T1 (de) * 1998-01-23 2002-08-15 Vernalis Res Ltd Azetidincarboxamidderivate zur behandlung von zns-erkrankungen

Also Published As

Publication number Publication date
JP2003505413A (ja) 2003-02-12
EP1196165A2 (fr) 2002-04-17
GB9917384D0 (en) 1999-09-22
WO2001007022A2 (fr) 2001-02-01
WO2001007022A3 (fr) 2001-06-14

Similar Documents

Publication Publication Date Title
AU1173201A (en) Skin-gripper
AU3092999A (en) Digital-timeshare-exchange
AU5967600A (en) Candystraw
AU6335000A (en) Depthimeter
AU4115400A (en) Short-circuiter
AU7514700A (en) Cyanopiperidines
AU6440900A (en) Homogentisate-dioxygenase
AU2804600A (en) Arylaminoalkylamides
AU2023701A (en) Sketcher
AU2699800A (en) Organoceramics
AU6098300A (en) Follistatin-3
AU4916900A (en) Benzofuranylsulfonates
AU4561600A (en) Benzofuranylaminoalcohols
AU6008000A (en) Chemical compounds-ii
AUPQ319799A0 (en) Chemical methods
AU1901801A (en) Glucofuranoses
AU7617200A (en) Chemical feeder
AU7303400A (en) Osseo-distractor
AU1915601A (en) Periotome
AU7513400A (en) Hydantoin-racemase
AU4435300A (en) Hula-hoop
AU2582200A (en) Windturbine
AU6006000A (en) Chemical compounds-iii
AU2197301A (en) Microlamp
AU5416100A (en) Retinoscopes

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
TH Corrigenda

Free format text: IN VOL 15, NO 20, PAGE(S) 4277-4282 UNDER THE HEADING APPLICATIONS LAPSED, REFUSED OR WITHDRAWN PLEASE DELETE ALL REFERENCE TO APPLICATION NO. 56729/00, 60060/00, 65573/00 AND 15456/01

MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase